MannKind Corp (MNKD)

1.26
0.01 0.80
NASDAQ : Health Care
Prev Close 1.25
Open 1.26
Day Low/High 1.23 / 1.29
52 Wk Low/High 0.64 / 5.37
Volume 778.91K
Avg Volume 3.64M
Exchange NASDAQ
Shares Outstanding 101.01M
Market Cap 131.31M
EPS 1.40
P/E Ratio 0.87
Div & Yield N.A. (N.A)

Latest News

MannKind Provides Update On Senior Management

Michael Castagna appointed Chief Executive Officer and Member of MannKind Board of Directors

MannKind Corporation Reports 2017 First Quarter Financial Results

Conference Call to Begin Today at 5:00 PM ET

Mannkind in Free Fall After Changes to Insulin Product, Sales Force

Mannkind in Free Fall After Changes to Insulin Product, Sales Force

Shares of insulin maker Mannkind plummeted on news of a proposed stock split, staffing changes and a new iteration of its insulin.

Mannkind Stock Drops Following Changes to Its Insulin Product

Mannkind Stock Drops Following Changes to Its Insulin Product

Mannkind stock is suffering, and the company appears to be in trouble.

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open

Other movers included Mannkind, Perrigo and Bristol-Myers Squibb.

Insulin Drug Offers Hope for MannKind

Insulin Drug Offers Hope for MannKind

The stock has taken a beating, but users of Afrezza are loyal to the drug.

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 tweets by TheStreet's Adam Feuerstein kept us informed and entertained. From an unexpected twist on New Year's day with MannKind to J.P. Morgan's Healthcare conference to Bristol-Myers Squibb's oops!

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

2016 Was a Terrible Year for Biotech but the Tweets Were on Point

A look back at the year's worth of Adam Feuerstein's biotech tweets.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.